Biomechanical forces in the aged brain: Relationship to AD

Gyeong Yun Lee1, Ok-Hyeon Kim1, Eun Ran Kim2

  • 1Department of Anatomy and Cell Biology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.

Life Sciences
|November 27, 2022
PubMed
Summary

This review explores how biomechanical forces in the brain change with age and in Alzheimer's disease. The authors suggest that these forces influence glial and neuronal function. They examine how substrate rigidity and fluid dynamics affect brain cells. The review highlights the need to understand how mechanical cues contribute to disease. The authors propose that current models may overlook biomechanical influences. They suggest that these forces interact with biochemical pathways in neurodegeneration. The findings indicate that biomechanical factors may play a role in disease progression. The authors conclude that integrating mechanical cues into disease models is essential.

Frequently Asked Questions

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
615
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
148
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
241